Information request – Various pharmaceutical products for the rescEU CBRN project

Summary

The Finnish Institute for Health and Welfare (THL) is conducting market research for a planned procurement of pharmaceutical products for the rescEU CBRN project. The potential procurement is expected to comprise five lots: gentamicin 40 mg/ml (2 ml, intravenous infusion), meropenem 1,000 mg per vial or ampoule (powder for infusion), benzylpenicillin 3 g (powder for infusion), and oseltamivir capsules in 30 mg and 75 mg strengths. Each product would form a separate lot; exact quantities are not stated in the public notice and are subject to a confidentiality procedure.